Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-08-014079
Filing Date
2008-10-31
Accepted
2008-10-31 16:25:30
Documents
1
Effectiveness Date
2008-10-31

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS y72175defa14a.htm DEFA14A 39549
  Complete submission text file 0000950123-08-014079.txt   41032
Mailing Address 225 SUMMIT AVE MONTVALE NJ 07645-1523
Business Address 225 SUMMIT AVE MONTVALE NJ 07645-1523 201-930-3300
BARR PHARMACEUTICALS INC (Filer) CIK: 0000010081 (see all company filings)

EIN.: 221927534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-09860 | Film No.: 081154859
SIC: 2834 Pharmaceutical Preparations